The primary novel findings in our study are that FNDC5 deficiency deteriorates, while FNDC5 overexpression attenuates HFD-induced cardiac hypertrophy, cardiac inflammation and oxidative stress. This evidence concerns the gene FNDC5 and cardiac hypertrophy.